Durability of Severe Acute Respiratory Syndrome Coronavirus 2 Messenger RNA Booster Vaccine Protection Against Omicron Among Healthcare Workers With a Vaccine Mandate.

Richterman, Aaron; Behrman, Amy; Brennan, Patrick J; O'Donnell, Judith A; Snider, Christopher K; Chaiyachati, Krisda H

Richterman, Aaron; Behrman, Amy; Brennan, Patrick J; O'Donnell, Judith A; Snider, Christopher K; Chaiyachati, Krisda H.

Afiliação

Richterman A; The University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
Behrman A; The University of Pennsylvania Health System, Philadelphia, Pennsylvania, USA.
Brennan PJ; The University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
O'Donnell JA; The University of Pennsylvania Health System, Philadelphia, Pennsylvania, USA.
Snider CK; The University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
Chaiyachati KH; The University of Pennsylvania Health System, Philadelphia, Pennsylvania, USA.

Clin Infect Dis ; 76(3): e319-e326, 2023 02 08.

Article em En | MEDLINE | ID: mdl-35666508

Assuntos

COVID-19; Vacinas; Humanos; Vacina BNT162; SARS-CoV-2; COVID-19/prevenção & controle; Pessoal de Saúde; Vacina de mRNA-1273 contra 2019-nCoV; RNA; RNA Mensageiro

Palavras-chave

BNT162b2; Omicron Variant; SARS-CoV-2; booster; healthcare worker; mRNA1273; vaccine effectiveness

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas / COVID-19 Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google